A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
Clinical trial NCT03473743 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03473743
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2022-09-30
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.